Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma

Mansi A Parasramka1, Sayantan Maji1, Akiko Matsuda1

  • 1Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.

Insights

Long non-coding RNAs (lncRNAs) are crucial regulators of cellular functions and disease. Targeting these complex RNA molecules, like in liver cancer, offers promising therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their significant roles in cellular physiology and disease.
  • These complex RNA molecules modulate gene expression through interactions with DNA, RNA, and proteins.
  • Aberrant lncRNA expression is linked to various pathological conditions, highlighting their disease relevance.

Purpose of the Study:

  • To review the diverse mechanisms of action and functional cellular roles of lncRNAs.
  • To explore the involvement of lncRNAs in disease pathogenesis.
  • To discuss therapeutic strategies targeting lncRNA-dependent mechanisms, using liver cancer as a model.

Main Methods:

  • Literature review of lncRNA mechanisms, functions, and disease involvement.
  • Focus on lncRNA-mediated gene regulation.
  • Case study analysis of therapeutic targeting in liver cancer.

Main Results:

  • lncRNAs employ multifaceted mechanisms to regulate gene expression.
  • Dysregulation of lncRNAs contributes to the development and progression of diseases.
  • Targeting lncRNAs presents novel therapeutic opportunities, particularly in oncology.

Conclusions:

  • lncRNAs are key players in cellular processes and disease.
  • Understanding lncRNA functions is vital for developing new therapeutic interventions.
  • Targeting lncRNAs holds significant promise for treating diseases like liver cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
16.2K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K